Xavier Dervillez

589 total citations
20 papers, 469 citations indexed

About

Xavier Dervillez is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Xavier Dervillez has authored 20 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Xavier Dervillez's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Herpesvirus Infections and Treatments (6 papers) and Immunotherapy and Immune Responses (6 papers). Xavier Dervillez is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Herpesvirus Infections and Treatments (6 papers) and Immunotherapy and Immune Responses (6 papers). Xavier Dervillez collaborates with scholars based in France, United States and Luxembourg. Xavier Dervillez's co-authors include Lbachir BenMohamed, Aziz Alami Chentoufi, Wolfgang F. Vogel, J. Cohen, Cyrile Anne Curat, Anthony B. Nesburn, Steven L. Wechsler, Xiuli Zhang, Thierry Tabary and Brigitte Réveil and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Xavier Dervillez

18 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Dervillez France 14 199 181 130 105 55 20 469
Stany Depraetere Belgium 9 178 0.9× 87 0.5× 77 0.6× 33 0.3× 28 0.5× 13 404
N R Cooper United States 8 263 1.3× 151 0.8× 74 0.6× 88 0.8× 24 0.4× 11 467
Victoria L. Crotzer United States 11 486 2.4× 261 1.4× 325 2.5× 41 0.4× 46 0.8× 13 811
Jiyi Yin United States 9 211 1.1× 134 0.7× 152 1.2× 42 0.4× 46 0.8× 9 491
Adem C. Koksal United States 9 130 0.7× 59 0.3× 247 1.9× 60 0.6× 20 0.4× 13 494
Nadine Cogné France 11 238 1.2× 305 1.7× 167 1.3× 84 0.8× 71 1.3× 13 748
Marie Lambelé United States 10 137 0.7× 97 0.5× 136 1.0× 30 0.3× 231 4.2× 11 425
Laura Arribillaga Spain 14 516 2.6× 188 1.0× 163 1.3× 58 0.6× 38 0.7× 22 819
Ursula Esser United States 12 499 2.5× 75 0.4× 173 1.3× 119 1.1× 151 2.7× 14 766
M. Kakinuma Japan 13 205 1.0× 91 0.5× 172 1.3× 32 0.3× 55 1.0× 23 497

Countries citing papers authored by Xavier Dervillez

Since Specialization
Citations

This map shows the geographic impact of Xavier Dervillez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Dervillez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Dervillez more than expected).

Fields of papers citing papers by Xavier Dervillez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Dervillez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Dervillez. The network helps show where Xavier Dervillez may publish in the future.

Co-authorship network of co-authors of Xavier Dervillez

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Dervillez. A scholar is included among the top collaborators of Xavier Dervillez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Dervillez. Xavier Dervillez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iserentant, Gilles, Ludovic Richert, Benoit Briard, et al.. (2025). Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia. EBioMedicine. 120. 105926–105926.
2.
Seguin‐Devaux, Carole, Gilles Iserentant, Iris Behrmann, et al.. (2025). Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer. ImmunoTargets and Therapy. Volume 14. 979–995.
3.
Dervillez, Xavier, Saskia Neubacher, Vladimir Bobkov, et al.. (2024). Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism. Biochemical Pharmacology. 227. 116457–116457. 4 indexed citations
4.
Iserentant, Gilles, Jacques Zimmer, Michel Moutschen, et al.. (2023). Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure. Journal of Translational Medicine. 21(1). 791–791. 6 indexed citations
5.
Seguin‐Devaux, Carole, et al.. (2019). FHR4‐based immunoconjugates direct complement‐dependent cytotoxicity and phagocytosis towards HER2‐positive cancer cells. Molecular Oncology. 13(12). 2531–2553. 18 indexed citations
8.
Chentoufi, Aziz Alami, Xavier Dervillez, Gargi Dasgupta, et al.. (2012). The Herpes Simplex Virus Type 1 Latency-Associated Transcript Inhibits Phenotypic and Functional Maturation of Dendritic Cells. Viral Immunology. 25(3). 67275057–67275057. 37 indexed citations
9.
Chentoufi, Aziz Alami, Xavier Dervillez, Pierre‐Alain Rubbo, et al.. (2012). Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.. PubMed. 13. 51–68. 13 indexed citations
11.
Dervillez, Xavier, Khaled W. Kabbara, Chelsea Nguyen, et al.. (2012). Future of an ‘Asymptomatic‘ T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine. Future Virology. 7(4). 371–378. 29 indexed citations
12.
Parfitt, Geraint J., Yilu Xie, Korey M. Reid, et al.. (2012). A Novel Immunofluorescent Computed Tomography (ICT) Method to Localise and Quantify Multiple Antigens in Large Tissue Volumes at High Resolution. PLoS ONE. 7(12). e53245–e53245. 30 indexed citations
13.
14.
Dervillez, Xavier, Jochen Schuhmacher, Christian Griesinger, et al.. (2006). Stable Expression of Soluble Therapeutic Peptides in Eukaryotic Cells by Multimerisation: Application to the HIV‐1 Fusion Inhibitory Peptide C46. ChemMedChem. 1(3). 330–339. 27 indexed citations
15.
Curat, Cyrile Anne, et al.. (2001). Mapping of Epitopes in Discoidin Domain Receptor 1 Critical for Collagen Binding. Journal of Biological Chemistry. 276(49). 45952–45958. 65 indexed citations
16.
Goossens, D., Xavier Dervillez, Brigitte Réveil, et al.. (2000). A Soluble Recombinant Multimeric Anti-Rh(D) Single-Chain Fv/CR1 Molecule Restores the Immune Complex Binding Ability of CR1-Deficient Erythrocytes. The Journal of Immunology. 164(3). 1505–1513. 35 indexed citations
17.
Shinya, Eiji, Xavier Dervillez, Florence Edwards‐Lévy, et al.. (1999). In-vivo delivery of therapeutic proteins by genetically-modified cells: comparison of organoids and human serum albumin alginate-coated beads. Biomedicine & Pharmacotherapy. 53(10). 471–483. 22 indexed citations
19.
Dervillez, Xavier, et al.. (1997). Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35) : vesiculation and/or proteolysis?. Immunopharmacology. 38(1-2). 129–140. 17 indexed citations
20.
Goossens, D., Xavier Dervillez, Grzegorz R. Juszczak, et al.. (1997). A Recombinant Human scFv Anti-Rh(D) Antibody With Multiple Valences Using a C-Terminal Fragment of C4-Binding Protein. Blood. 90(10). 3978–3983. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026